Poelstra, Klaas
Article History
First Online: 13 January 2016
Competing interests
: K.P. is co-founder and minority shareholder in BiOrion Technologies. The antifibrotic compounds developed by BiOrion Technologies are not the subject of this Year-in-Review and are not mentioned in any other way in the article.